HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Pier Giorgio Natali Selected Research

Sunscreening Agents (Sunscreens)

3/2011[Skin cancer risk factors in childhood: findings of a survey conducted within Italian areas with a different incidence of melanoma].
9/2010Skin cancer risk factors among primary school children: investigations in Western Hungary.
1/2009[Skin cancer risk factors in childhood: findings of a survey in an Italian area characterized by atypical migration].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Pier Giorgio Natali Research Topics

Disease

55Neoplasms (Cancer)
09/2015 - 07/2002
25Carcinoma (Carcinomatosis)
04/2011 - 08/2002
19Melanoma (Melanoma, Malignant)
04/2014 - 09/2002
14Ovarian Neoplasms (Ovarian Cancer)
12/2014 - 08/2002
10Breast Neoplasms (Breast Cancer)
06/2014 - 02/2004
8Neoplasm Metastasis (Metastasis)
03/2013 - 08/2002
5Anoxia (Hypoxia)
04/2014 - 08/2002
4Neuroblastoma
01/2012 - 08/2003
3Melanosis (Freckles)
03/2011 - 01/2009
3Sunburn
03/2011 - 01/2009
2Adenocarcinoma
08/2013 - 08/2008
2Testicular Neoplasms (Testicular Cancer)
05/2008 - 04/2006
2Ascites
06/2006 - 08/2002

Drug/Important Bio-Agent (IBA)

22Endothelin-1 (Endothelin 1)IBA
04/2014 - 08/2002
15Endothelin A ReceptorIBA
12/2014 - 11/2002
10Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2014 - 08/2002
10AntigensIBA
01/2014 - 07/2002
9Endothelins (Endothelin)IBA
04/2014 - 01/2004
7Messenger RNA (mRNA)IBA
10/2010 - 08/2002
6Proteins (Proteins, Gene)IBA
06/2014 - 11/2004
6ZD4054IBA
04/2011 - 06/2006
6Epidermal Growth Factor Receptor (EGF Receptor)IBA
01/2010 - 11/2004
6A 127722IBA
04/2006 - 08/2002
5AntibodiesIBA
04/2014 - 05/2004
5Carbon MonoxideIBA
01/2014 - 01/2003
5Epidermal Growth Factor (EGF)IBA
07/2007 - 01/2006
4Endothelin Receptors (Endothelin Receptor)IBA
03/2013 - 08/2002
4Complementary DNA (cDNA)IBA
06/2006 - 09/2002
3Vascular Endothelial Growth Factor CIBA
04/2014 - 03/2009
3LigandsIBA
01/2014 - 11/2004
3Cadherins (E-Cadherin)IBA
01/2012 - 11/2004
3Sunscreening Agents (Sunscreens)IBA
03/2011 - 01/2009
3MART-1 AntigenIBA
09/2010 - 01/2009
3Paclitaxel (Taxol)FDA LinkGeneric
06/2010 - 11/2004
3Endothelin B ReceptorIBA
01/2010 - 02/2004
3beta CateninIBA
02/2009 - 11/2004
3PeptidesIBA
01/2009 - 05/2004
3Protein Kinases (Protein Kinase)IBA
07/2007 - 11/2004
3Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
02/2007 - 07/2004
3atrasentanIBA
11/2004 - 11/2002
3Connexin 43 (Connexin43)IBA
11/2004 - 10/2003
2Small Interfering RNA (siRNA)IBA
04/2014 - 03/2009
2Conditioned Culture MediaIBA
04/2014 - 01/2012
2glucuronyl glucosamine glycan sulfate (Vessel)IBA
04/2014 - 03/2006
2Biological Markers (Surrogate Marker)IBA
03/2013 - 02/2004
2Dacarbazine (DIC)FDA LinkGeneric
09/2010 - 01/2009
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
09/2010 - 01/2009
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
08/2010 - 02/2009
2beta-arrestinIBA
08/2010 - 02/2009
2integrin-linked kinaseIBA
08/2010 - 04/2006
2taxaneIBA
06/2010 - 05/2003
2Cancer VaccinesIBA
01/2009 - 01/2009
2Caspase 3 (Caspase-3)IBA
07/2007 - 06/2006
2Progesterone Receptors (Progesterone Receptor)IBA
07/2007 - 03/2006
2decitabine (5-aza-2'-deoxycytidine)FDA Link
03/2007 - 04/2006
2Endothelin-3 (Endothelin 3)IBA
02/2007 - 11/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2007 - 11/2004
2TeaIBA
06/2006 - 06/2006
2Tyrosine (L-Tyrosine)FDA Link
06/2006 - 10/2003
2epigallocatechin gallate (epigallocatechin-3-gallate)IBA
06/2006 - 06/2006
2Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
01/2005 - 08/2003
2Stem Cell FactorIBA
01/2005 - 08/2003
2Dinoprostone (PGE2)FDA Link
11/2004 - 11/2004
2A 192621IBA
11/2004 - 02/2004
2Cyclooxygenase 1IBA
11/2004 - 07/2004
1ArrestinIBA
12/2014
1N- (5- (4- bromophenyl)- 6- (2- (5- bromopyrimidin- 2- yloxy)ethoxy)pyrimidin- 4- yl)- N'- propylaminosulfonamideIBA
12/2014
1HLA-G antigen (HLA G)IBA
01/2014
1HLA-B Antigens (HLA-B)IBA
01/2014
1HLA-A Antigens (HLA-A)IBA
01/2014
1HLA-C Antigens (HLA-C)IBA
01/2014
1ParaffinIBA
08/2013
1MicroRNAs (MicroRNA)IBA
08/2013
1Formaldehyde (Formol)FDA Link
08/2013
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
03/2013
1GTP-Binding Proteins (G-Protein)IBA
03/2013
1Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA
03/2013
1Phospholipases (Phospholipase)IBA
03/2013
1Vascular Endothelial Growth Factor DIBA
03/2013
1Lamin Type A (Lamin A)IBA
01/2012
1VimentinIBA
01/2012
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2012
1Ovarian epithelial cancerIBA
04/2011
1ORALIT (ORS)IBA
03/2011
1CP-870,893IBA
10/2010
1glycogen synthase kinase 3 betaIBA
08/2010
1PlatinumIBA
06/2010
1AminopeptidasesIBA
02/2010
1NF-kappa B (NF-kB)IBA
02/2010
1phosphatidylcholine-specific phospholipase CIBA
01/2010
1Endothelin-2 (Endothelin 2)IBA
01/2010
1Procollagen-Proline Dioxygenase (Prolyl Hydroxylase)IBA
01/2010
1Glycogen Synthase KinasesIBA
02/2009
1ArrestinsIBA
02/2009
1Melanoma-Specific AntigensIBA
01/2009

Therapy/Procedure

18Heterologous Transplantation (Xenotransplantation)
01/2015 - 11/2002
5Immunotherapy
09/2015 - 04/2006
5Drug Therapy (Chemotherapy)
12/2014 - 02/2004
1Adjuvant Chemotherapy
03/2013
1Lasers (Laser)
01/2010